Literature DB >> 11397976

Domino hepatic transplantation using the liver from a patient with primary hyperoxaluria.

V Donckier1, I El Nakadi, J Closset, B Ickx, H Louis, O Le Moine, N Bourgeois, M Adler, M Gelin.   

Abstract

BACKGROUND: We report a case of domino liver transplantation using the liver harvested from a patient who underwent a combined liver and kidney transplantation for primary hyperoxaluria (PH).
METHOD: A cadaveric liver transplantation was performed in a 19-year-old man with PH. In a second step, the PH liver harvested from the first patient was transplanted in a 69-year-old man with hepatitis C-related cirrhosis, not a candidate for a classic liver graft owing to multifocal hepatocellular carcinoma.
RESULTS: At 8 months after transplantation, the domino recipient has normal hepatic function and no signs of tumoral recurrence, but he progressively developed hyperoxalemia, hyperoxaluria, and renal insufficiency.
CONCLUSION: Regarding the favorable postoperative clinical evolution, domino liver transplantations using livers from PH patients may represent a new opportunity for marginal candidates for liver transplantation. However, the progressive renal insufficiency expected in such domino recipients should limit this procedure to selected cases.

Entities:  

Mesh:

Year:  2001        PMID: 11397976     DOI: 10.1097/00007890-200105150-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Liver transplantation for primary hyperoxaluria type 1: a single-center experience during two decades in Japan.

Authors:  Tomohide Hori; Hiroto Egawa; Toshimi Kaido; Kohei Ogawa; Shinji Uemoto
Journal:  World J Surg       Date:  2013-03       Impact factor: 3.352

2.  Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.

Authors:  Neslihan Celik; Beau Kelly; Kyle Soltys; James E Squires; Jerry Vockley; Diana A Shellmer; Kevin Strauss; Patrick McKiernan; Armando Ganoza; Rakesh Sindhi; Geoffrey Bond; George Mazariegos; Ajai Khanna
Journal:  Clin Transplant       Date:  2019-10-06       Impact factor: 2.863

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.